Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

Bruker Corporation designs, manufactures, and markets proprietary life science systems based on spectrometry technology platforms. The Company also sells a range of field analytical systems for substance detection and pathogen identification. Bruker develops life science and advanced materials research tools based on X-ray technology.
Website: bruker.com


  • Bad financial results growth rate -46.7% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (-10.2%)
  • Dividend yield for the last twelve months 0.4%
  • Free cash flow yield 9.6% (LTM)
  • Share price is 94.4% higher than minimum and 39.5% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (50.7x vs 30.0x)
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $0.4 mln (-0.005% of cap.)

Key Financials (Download financials)

Ticker: BRKR
Share price, USD:  (-8.0%)57.07
year average price 52.21  


year start price 38.94 2025-11-02

min close price 38.71 2025-11-03

max close price 64.85 2026-09-30

current price 57.07 2026-11-01
Common stocks: 149 255 013

Dividend Yield:  0.4%
FCF Yield LTM: 9.6%
EV / LTM EBITDA: 50.7x
EV / Sales: 2.9x
Margin (EBITDA LTM / Revenue): 5.7%

Target EV / EBITDA (hist percentile): 30.0x
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 8 518
Net Debt ($m): 1 630
EV (Enterprise Value): 10 148
EBITDA LTM (млн $): 200
EV / LTM EBITDA: 50.7x
Price to Book: 3.8x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2026-01-23seekingalpha.com

Artisan Small Cap Fund Q4 2025 Portfolio Activity

2025-12-26zacks.com

Should You Continue to Hold BRKR Stock in Your Portfolio?

2025-06-30zacks.com

BRKR Stock Gains Following the Multi-System Advanced Packaging Order

2025-04-23globenewswire.com

Solis Agrosciences Names Crystal Winkeler Chief Business Officer to Drive Commercial Growth

2025-01-14zacks.com

BRKR Stock Up on the Launch of LUMOS II ILIM QCL-Based IR Microscope

2024-11-12zacks.com

New Strong Sell Stocks for November 12th

2024-11-11zacks.com

BRKR Stock Declines Despite Launching EpicIF Technology for CellScape

2024-11-07zacks.com

BRKR Misses on Q3 Earnings, Cuts '24 View, Stock Up in Aftermarket

2024-10-17globenewswire.com

Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress

2024-10-09zacks.com

BRKR Stock Might Gain From the Newly Launched OptoVolt Module
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-05 2025-08-06 2024-11-05 2024-08-09 2024-05-10 2023-11-09 2023-08-09 2023-05-10 2022-11-04
acceptedDate 2025-11-05 16:30:06 2025-08-05 19:05:54 2025-03-03 16:27:32 2024-11-05 07:00:10 2024-08-09 16:41:48 2024-05-10 15:29:53 2024-02-29 15:58:08 2023-11-09 16:54:36 2023-08-09 15:27:25 2023-05-10 15:10:36 2022-12-31 00:00:00 2022-11-04 15:11:06 2022-02-28 10:46:59 2021-03-01 15:37:40
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 861M 797M 3 366M 864M 801M 722M 2 965M 743M 682M 685M 2 531M 639M 2 418M 1 988M
costOfRevenue 474M 440M 1 717M 454M 411M 365M 1 451M 360M 341M 326M 1 225M 304M 1 208M 1 048M
grossProfit 386M 358M 1 650M 410M 390M 357M 1 513M 383M 341M 360M 1 306M 335M 1 210M 940M
grossProfitRatio 0.449 0.449 0.475 0.486 0.494 0.515 0.499 0.525 0.525
researchAndDevelopmentExpenses 98M 100M 377M 98M 92M 82M 295M 71M 71M 69M 236M 56M 221M 198M
generalAndAdministrativeExpenses 0 0 894M 239M 221M 195M 730M 178M 178M 163M 610M 145M 562M 478M
sellingAndMarketingExpenses 0 0 0 -9M 300 000 300 000 -600 000 0 0 0 -2M 0 0 0
sellingGeneralAndAdministrativeExpenses 227M 231M 894M 230M 221M 195M 729M 178M 178M 163M 607M 145M 562M 478M
otherExpenses -6M 14M 126M 14M -2M -800 000 52M -9M -5M -5M 30M 0 13M 16M
operatingExpenses 319M 346M 1 396M 351M 315M 278M 1 076M 249M 249M 232M 873M 201M 796M 692M
costAndExpenses 794M 786M 3 113M 796M 727M 650M 2 528M 609M 590M 557M 2 098M 505M 2 005M 1 739M
interestIncome 0 3M 9M 2M 2M 3M 8M 2M 2M 1M 3M 0 900 000 3M
interestExpense 20M 16M 48M 12M 16M 7M 16M -5M -9M -16M 16M -2M 14M 14M
depreciationAndAmortization 56M 56M 184M 51M 45M 35M 115M 27M 26M 30M 89M 24M 89M 80M
ebitda 3M 72M 439M 119M 126M 113M 676M 161M 118M 153M 519M 155M 497M 321M
ebitdaratio 0.004 0.091 0.138 0.149 0.157 0.216 0.172 0.223 0.243
operatingIncome 67M 12M 253M 68M 74M 79M 437M 125M 86M 123M 433M 131M 413M 248M
operatingIncomeRatio 0.078 0.015 0.079 0.093 0.109 0.168 0.126 0.179 0.206
totalOtherIncomeExpensesNet -140M -11M -48M -13M -24M -7M 109M -9M -5M -16M -18M -2M -20M -23M
incomeBeforeTax -73M 1M 205M 55M 24M 72M 546M 119M 78M 107M 415M 129M 394M 226M
incomeBeforeTaxRatio -0.084 0.001 0.064 0.03 0.099 0.16 0.114 0.156 0.202
incomeTaxExpense -14M -3M 91M 15M 16M 20M 118M 31M 20M 30M 116M 41M 113M 64M
netIncome -60M 8M 113M 41M 8M 51M 427M 88M 57M 77M 297M 88M 277M 158M
netIncomeRatio -0.069 0.01 0.047 0.009 0.071 0.119 0.084 0.112 0.138
eps -0.411 0.05 0.76 0.28 0.052 0.35 2.92 0.6 0.39 0.52 2 0.6 1.83 1.03
epsdiluted -0.411 0.05 0.28 0.051 0.35 0.6 0.39 0.52 0.59
weightedAverageShsOut 152M 152M 149M 148M 147M 145M 146M 147M 147M 147M 149M 148M 151M 153M
weightedAverageShsOutDil 152M 152M 150M 149M 148M 146M 147M 147M 148M 148M 149M 149M 153M 155M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-03 2024-02-29 2022-12-31 2022-02-28 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome -39M -9M -13M -13M -11M
ebit 255M 561M 430M 408M 240M
nonOperatingIncomeExcludingInterest -2M -124M 3M 5M 8M
netIncomeFromContinuingOperations 114M 429M 299M 281M 161M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 113M 427M 297M 277M 158M
epsDiluted 0.76 2.9 1.99 1.81 1.02

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-05 2025-08-06 2024-11-05 2024-08-09 2024-05-10 2023-11-09 2023-08-09 2023-05-10 2022-11-04
acceptedDate 2025-11-05 16:30:06 2025-08-05 19:05:54 2025-03-03 16:27:32 2024-11-05 07:00:10 2024-08-09 16:41:48 2024-05-10 15:29:53 2024-02-29 15:58:08 2023-11-09 16:54:36 2023-08-09 15:27:25 2023-05-10 15:10:36 2022-12-31 00:00:00 2022-11-04 15:11:06 2022-02-28 10:46:59 2021-03-01 15:37:40
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 295M 92M 183M 148M 170M 340M 488M 364M 575M 598M 646M 626M 1 068M 682M
shortTermInvestments 0 0 0 0 13M 13M 0 19M 0 0 0 0 100M 50M
cashAndShortTermInvestments 295M 92M 183M 148M 170M 340M 488M 364M 575M 598M 646M 626M 1 168M 732M
netReceivables 673M 739M 701M 538M 694M 636M 622M 485M 451M 472M 595M 421M 417M 335M
inventory 1 197M 1 218M 1 068M 1 220M 1 176M 1 061M 968M 916M 915M 859M 800M 750M 710M 692M
otherCurrentAssets 186M 114M 40M 285M 113M 104M 30M 264M 243M 208M 29M 240M 177M 166M
totalCurrentAssets 2 351M 2 163M 2 053M 2 191M 2 153M 2 140M 2 164M 2 029M 2 183M 2 136M 2 113M 2 037M 2 472M 1 925M
propertyPlantEquipmentNet 747M 759M 815M 694M 793M 691M 691M 527M 523M 511M 538M 422M 466M 463M
goodwill 1 550M 1 649M 1 507M 1 475M 1 444M 752M 583M 561M 558M 527M 458M 382M 340M 320M
intangibleAssets 919M 970M 913M 1 027M 1 024M 449M 331M 292M 300M 299M 271M 214M 212M 229M
goodwillAndIntangibleAssets 2 469M 2 619M 2 420M 2 501M 2 468M 1 201M 913M 1 262M 1 151M 1 117M 729M 879M 551M 550M
longTermInvestments 8M 0 0 0 11M 22M 0 19M 0 0 0 0 0 0
taxAssets 0 0 286M 0 303M 280M 297M -410M 0 0 77M 0 90M 72M
otherNonCurrentAssets 861M 800M 233M 727M 174M 172M 184M 391M 0 0 155M 0 71M 40M
totalNonCurrentAssets 4 084M 4 177M 3 754M 3 922M 3 750M 2 366M 2 086M 1 789M 1 674M 1 628M 1 499M 1 300M 1 178M 1 124M
otherAssets 0 0 0 0 0 1 0 0 0 0 0 0 0 0
totalAssets 6 435M 6 340M 5 807M 6 113M 5 903M 4 506M 4 250M 3 818M 3 857M 3 764M 3 612M 3 337M 3 650M 3 049M
accountPayables 184M 243M 234M 228M 220M 199M 203M 182M 189M 196M 178M 158M 147M 135M
shortTermDebt 24M 56M 33M 33M 26M 21M 121M 121M 121M 120M 19M 17M 112M 2M
taxPayables 0 0 143M 0 0 0 157M 0 0 0 104M 0 91M 117M
deferredRevenue 0 478M 438M 467M 502M 485M 400M 381M 397M 401M 370M 176M 336M 307M
otherCurrentLiabilities 1 059M 571M 300M 595M 556M 477M 218M 389M 344M 334M 160M 514M 156M 121M
totalCurrentLiabilities 1 268M 1 347M 1 281M 1 322M 1 305M 1 183M 1 202M 1 072M 1 051M 1 052M 914M 865M 939M 792M
longTermDebt 2 025M 2 380M 2 062M 2 265M 2 243M 1 357M 1 160M 1 099M 1 123M 1 109M 1 201M 1 137M 1 222M 842M
deferredRevenueNonCurrent 0 0 100M 0 94M 106M 92M 0 0 0 102M 0 50M 51M
deferredTaxLiabilitiesNonCurrent 0 0 119M 0 179M 82M 68M 0 0 0 62M 0 46M 43M
otherNonCurrentLiabilities 649M 746M 311M 701M 258M 328M 240M 403M 421M 392M 167M 1 168M 267M 300M
totalNonCurrentLiabilities 2 674M 3 126M 2 710M 2 966M 2 774M 1 873M 1 635M 1 502M 1 544M 1 501M 1 566M 1 519M 1 627M 1 283M
otherLiabilities 0 0 0 -18M 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 19M 0 151M 0 111M 86M 98M 20M 0 0 51M 0 60M 68M
totalLiabilities 3 943M 4 473M 3 992M 4 270M 4 078M 3 056M 2 837M 2 574M 2 594M 2 553M 2 480M 2 383M 2 565M 2 075M
preferredStock 0 0 0 0 0 16M 0 0 0 0 0 0 0 0
commonStock 2M 2M 2M 0 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
retainedEarnings 2 352M 2 416M 2 407M 0 2 367M 2 367M 2 324M 0 0 0 1 926M 0 1 660M 1 407M
accumulatedOtherComprehensiveIncomeLoss -79M -97M -104M -62M -44M -8M 6M -5M 24M 30M 15M -92M -8M 4M
othertotalStockholdersEquity 157M -517M 1 887M -536M -962M 1 231M 1 225M 1 168M 1 038M
totalStockholdersEquity 2 432M 1 804M 1 781M 1 825M 1 789M 1 415M 1 377M 1 227M 1 251M 1 199M 1 114M 948M 1 071M 961M
totalEquity 2 492M 1 867M 1 815M 1 843M 1 825M 1 451M 1 413M 1 244M 1 263M 1 199M 1 132M 948M 1 085M 974M
totalLiabilitiesAndStockholdersEquity 6 435M 6 340M 6 113M 5 903M 4 506M 3 818M 3 857M 3 764M 3 337M
minorityInterest 61M 63M 34M 18M 35M 36M 36M 17M 12M 12M 18M 0 14M 13M
totalLiabilitiesAndTotalEquity 6 435M 6 340M 5 807M 6 113M 5 903M 4 506M 4 250M 3 818M 3 857M 3 764M 3 612M 3 337M 3 650M 3 049M
totalInvestments 8M 0 0 0 11M 22M 0 19M 0 0 0 0 100M 50M
totalDebt 2 049M 2 435M 2 245M 2 297M 2 270M 1 464M 1 380M 1 220M 1 243M 1 229M 1 270M 1 154M 1 394M 913M
netDebt 1 754M 2 343M 2 062M 2 149M 2 100M 1 124M 891M 856M 669M 631M 625M 528M 326M 231M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-03 2024-02-29 2022-12-31 2022-02-28 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 566M 492M 473M 417M 335M
otherReceivables 136M 130M 123M 0 0
prepaids 61M 56M 43M 0 0
totalPayables 377M 360M 282M 238M 251M
otherPayables 143M 157M 104M 91M 117M
accruedExpenses 102M 79M 67M 78M 89M
capitalLeaseObligationsCurrent 32M 23M 16M 18M 21M
capitalLeaseObligationsNonCurrent 119M 75M 35M 42M 47M
treasuryStock -1 237M -1 237M -1 085M -820M -667M
additionalPaidInCapital 713M 283M 256M 238M 216M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-05 2025-08-06 2024-11-05 2024-08-09 2024-05-10 2023-11-09 2023-08-09 2023-05-10 2022-11-04
acceptedDate 2025-11-05 16:30:06 2025-08-05 19:05:54 2025-03-03 16:27:32 2024-11-05 07:00:10 2024-08-09 16:41:48 2024-05-10 15:29:53 2024-02-29 15:58:08 2023-11-09 16:54:36 2023-08-09 15:27:25 2023-05-10 15:10:36 2022-12-31 00:00:00 2022-11-04 15:11:06 2022-02-28 10:46:59 2021-03-01 15:37:40
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome -59M 4M 114M 41M 8M 51M 427M 89M 58M 77M 299M 88M 281M 161M
depreciationAndAmortization 56M 56M 184M 51M 45M 35M 115M 27M 26M 25M 89M 21M 89M 81M
deferredIncomeTax -27M -16M -64M -22M -20M -2M -24M 3M 8M 1M -15M -18M -6M -23M
stockBasedCompensation 0 0 25M 6M 7M 5M 24M 6M 6M 5M 28M 5M 17M 16M
changeInWorkingCapital -118M -160M -78M -47M -58M -63M -88M -85M -100M -24M -144M -36M -125M 70M
accountsReceivables 0 0 -41M -19M 14M 16M -900 000 -43M 22M 8M -68M -35M -95M 41M
inventory 0 0 -70M -11M -29M -65M -125M -34M -59M -55M -138M -35M -67M -92M
accountsPayables 0 0 21M 21M 9M -4M 23M 14M -17M 14M 33M 18M 62M -2M
otherWorkingCapital -118M -160M 11M -38M -52M -11M 15M -23M -47M 9M 28M 17M -25M 123M
otherNonCashItems 114M -12M 70M 9M 123M 124M -104M 5M 16M 2M 18M 8M 27M 27M
netCashProvidedByOperatingActivities -33M -128M 251M 38M 1M 22M 350M 44M 13M 88M 274M 70M 282M 332M
investmentsInPropertyPlantAndEquipment -21M -21M -115M -33M -25M -21M -107M -27M -24M -25M -129M -58M -92M -97M
acquisitionsNet -200 000 -68M -1 600M -200 000 -1 302M -275M -227M -120M -3M -88M -182M -100 000 -65M -59M
purchasesOfInvestments 0 0 -48M 0 0 -10M -25M -10M -1M -8M -60M -3M -149M -151M
salesMaturitiesOfInvestments 0 0 5M -3M 1M 1M 21M 1M 1M 2M 106M 3M 108M 115M
otherInvestingActivites -3M -1M -32M 1M 1M 200 000 0 11M 0
netCashUsedForInvestingActivites -24M -91M -68M -1 325M -305M -155M -26M -108M -58M
debtRepayment -416M 103M 14M 759M -157M -6M -6M -6M -1M
commonStockIssued -1M -400 000 800 000 404M 3M 2M 2M 700 000 -3M
commonStockRepurchased 0 0 0 0 0 0 -152M -80M 3M -22M -263M -73M -153M -123M
dividendsPaid 0 -8M -8M -8M -7M -7M -7M -7M -7M
otherFinancingActivites 676M 1 000 000 -10M 1 000 000 -900 000 -1M -2M 4M 2M
netCashUsedProvidedByFinancingActivities 258M 96M -3M 1 156M 153M -93M -10M -31M -82M
effectOfForexChangesOnCash -300 000 32M -29M 10M -2M -18M 12M -8M 100 000 4M -31M -27M -23M 26M
netChangeInCash 201M -92M -305M -18M -170M -148M -157M -211M -23M -47M -423M -97M 386M 4M
cashAtEndOfPeriod 297M 96M 187M 152M 170M 340M 492M 367M 578M 601M 649M 629M 1 072M 686M
cashAtBeginningOfPeriod 96M 188M 492M 170M 340M 488M 649M 578M 601M 649M 1 072M 726M 686M 682M
operatingCashFlow -33M -128M 251M 38M 1M 22M 350M 44M 13M 88M 274M 70M 282M 332M
capitalExpenditure -21M -21M -115M -33M -25M -21M -107M -27M -24M -25M -129M -58M -92M -97M
freeCashFlow -54M -149M 136M 6M -24M 400 000 243M 17M -11M 63M 145M 12M 190M 235M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-03 2024-02-29 2022-12-31 2022-02-28 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 1M 11M 14M 5M 200 000
netCashProvidedByInvestingActivities -1 757M -326M -252M -192M -193M
netDebtIssuance 876M -22M -111M 490M -8M
longTermNetDebtIssuance 876M -22M -111M 490M -8M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 403M -143M -263M -146M -120M
netCommonStockIssuance 403M -143M -263M -146M -120M
commonStockIssuance 403M 10M 0 7M 3M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid -30M -29M -30M -24M -25M
commonDividendsPaid -30M -29M -30M -24M -25M
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -19M 300 000 -12M -500 000 -9M
netCashProvidedByFinancingActivities 1 230M -193M -415M 319M -162M
incomeTaxesPaid 154M 97M 147M 146M 43M
interestPaid 55M 34M 24M 20M 29M

Earning call transcript

2025 q3
2025-11-03 ET (fiscal 2025 q3)
2025 q2
2025-08-04 ET (fiscal 2025 q2)
2025 q1
2025-05-07 ET (fiscal 2025 q1)
2024 q4
2025-02-13 ET (fiscal 2024 q4)
2024 q3
2024-11-05 ET (fiscal 2024 q3)
2024 q2
2024-08-09 ET (fiscal 2024 q2)
2024 q1
2024-05-02 ET (fiscal 2024 q1)
2023 q4
2024-02-13 ET (fiscal 2023 q4)
2023 q3
2023-11-03 ET (fiscal 2023 q3)
2023 q2
2023-08-03 ET (fiscal 2023 q2)
2023 q1
2023-05-06 ET (fiscal 2023 q1)
2022 q4
2023-02-09 ET (fiscal 2022 q4)
2022 q3
2022-11-05 ET (fiscal 2022 q3)
2022 q2
2022-08-03 ET (fiscal 2022 q2)
2022 q1
2022-05-04 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2026-08-11 ET
Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories
2026-08-10 ET
Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development
2026-08-04 ET
Bruker Reports Second Quarter 2026 Financial Results
2026-07-24 ET
Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast
2026-07-15 ET
Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood
2026-06-04 ET
Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026
2026-06-02 ET
Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry
2026-06-01 ET
Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease Biology
2026-05-26 ET
Champalimaud Foundation’s Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI
2026-05-06 10:30 ET
Bruker Reports First Quarter 2026 Financial Results
2026-04-24 11:00 ET
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast
2026-04-17 ET
Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026
2026-04-17 ET
Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026
2026-04-17 ET
Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management
2026-04-13 ET
Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026
2026-04-07 ET
Bruker Invests in Photothermal AFM-IR to Advance Semiconductor Research
2026-04-01 ET
Bruker Announces Appointment of Thierry Bernard to its Board of Directors
2026-03-31 ET
PreOmics GmbH and Biognosys AG Prevail in U.S. Patent Challenge
2026-02-25 ET
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR
2026-02-24 ET
Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications
2026-02-23 ET
Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum
2026-02-23 ET
Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology
2026-02-12 12:00 ET
Bruker Reports Fourth Quarter and Full Year 2025 Financial Results
2026-02-09 12:00 ET
Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC
2026-02-09 12:00 ET
Chemspeed and SciY Announce Self‑Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration
2026-02-05 21:05 ET
Bruker Announces Quarterly Preferred Stock Dividend
2026-02-05 13:00 ET
Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and Webcast
2026-01-09 ET
Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI
2026-01-08 ET
Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied Markets
2025-12-22 ET
RI Research Instruments Announces Major Orders for Enabling Technology for the Gamma-Ray Source of the Extreme Light Infrastructure (ELI)
2025-12-10 ET
Bruker Announces Orders for High-Performance Magnetic Resonance Systems for Materials and Life-Science Research from Leading European Institutions
2025-12-08 ET
Bruker Announces the Addition of Diagnostics Industry Leader Jack Phillips to its Board of Directors as of January 2026
2025-11-24 ET
Indaba Capital Announces Sale of AST Revolution to Bruker
2025-11-04 ET
Bruker Announces Quarterly Common Stock Dividend and Preferred Stock Dividend
2025-11-03 12:00 ET
Bruker Reports Third Quarter 2025 Financial Results
2025-10-22 ET
Bruker Announces Date and Time of Third Quarter 2025 Earnings Release and Webcast
2025-09-03 ET
Bruker Announces Pricing of Public Offering of $600 Million of 6.375% Mandatory Convertible Preferred Stock
2025-09-02 ET
Bruker Announces Public Offering of $600 Million of Mandatory Convertible Preferred Stock
2025-08-12 ET
Bruker Announces Quarterly Dividend
2025-08-06 ET
Bruker Secures Multi-Year Contracts for Explosives and Chemical Trace Detection in Aviation and Defense Sectors
2025-08-04 ET
Bruker Reports Second Quarter 2025 Financial Results
2025-07-21 ET
Bruker Announces Second Quarter 2025 Preliminary Results, Plans to Hold Q2 Earnings Conference Call on August 4, 2025
2025-06-24 ET
Bruker Experiences Growth in Semiconductor Advanced Packaging Market Fueled by AI Demands
2025-06-03 ET
Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection
2025-06-03 ET
Bruker Announces Acquisition of biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics
2025-06-02 ET
Bruker Launches New timsUltra AIP System with Further Enhanced, Extreme Sensitivity for Single-Cell Proteomics, FNA Biopsy Immunopeptidomics and Metaproteomics
2025-06-02 ET
Bruker Unveils New proteoElute™ nanoLC System and PepSep® Advanced nLC Columns for up to 50% Improved Peptide Sensitivity
2025-05-30 ET
Bruker Corporation to Present at the Jefferies Global Healthcare Conference
2025-05-30 ET
Bruker Launches Revolutionary timsOmniTM Mass Spectrometer
2025-05-30 ET
Bruker Launches Novel timsMetabo™ Mass Spectrometer for Breakthrough 4D-Metabolomics and 4D-Lipidomics Sensitivity, Specificity and Annotation Confidence - at Speed, Depth, and Scale
2025-05-28 ET
Bruker Introduces Novel MOVE-T System for Transferable, Robust Milk and Liquid Dairy Analysis with FT-NIR Technology
2025-05-15 ET
Bruker Announces Quarterly Dividend
2025-05-14 ET
Bruker and 10x Genomics Reach Global Settlement of Patent Litigation
2025-05-07 ET
Bruker Reports First Quarter 2025 Financial Results
2025-04-25 ET
Bruker Spatial Biology Pushes Boundaries in Spatial Biology and Multiomics at AACR 2025
2025-04-24 ET
Bruker to Launch Beacon Discovery™ at AACR 2025, Expanding Access to Live Single-Cell Functional Analysis
2025-04-17 ET
Bruker Introduces nVista 2P Miniature Microscope
2025-04-16 ET
Bruker Announces Majority Acquisition of RECIPE, a Leading Provider of Mass Spectrometry-based Diagnostic Assay Kits for Therapeutic Drug Monitoring
2025-04-11 ET
Bruker Announces First Quarter 2025 Preliminary Revenue
2025-04-11 ET
Bruker Complements Fast, Cost-effective IR Biotyper® Hospital Hygiene Testing and HAI Tracing with NGS Reflex Testing
2025-04-07 ET
Bruker Announces First-of-a-kind 1.3 GHz High-Resolution NMR System
2025-04-07 ET
Bruker Introduces Innovative Fourier 80 Multinuclear Benchtop FT-NMR
2025-04-02 ET
Bruker Announces Introduction of Revolutionary d-DNP Polarizer for MRI Research and for Dynamic Nuclear Polarization Liquids NMR
2025-02-27 ET
Bruker Launches X4 POSEIDON™ Advanced X-Ray Microscope for Three-Dimensional Microscopy in Industrial and Scientific Applications
2025-02-24 ET
Bruker Advances Single-Cell Proteomics and Immunopeptidomics Performance; Unveils New Proteomics Software and Applications for Enhanced Biological Insights at US HUPO
2025-02-21 ET
Bruker Spatial Biology to Announce Groundbreaking Advances at AGBT 2025
2025-02-21 ET
Bruker Announces Quarterly Dividend
2025-02-20 ET
Bruker Corporation to Present at Upcoming Investor Conferences
2025-02-13 ET
Bruker Reports Fourth Quarter and Full Year 2024 Financial Results
2025-02-07 ET
Bruker Announces Date and Time of Fourth Quarter 2024 Earnings Release and Webcast
2025-01-08 ET
Bruker Launches Infrared Imaging Microscope for Pharma and Life Science Research
2025-01-07 ET
Bruker Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference
2024-12-24 ET
Bruker Comments on Delaware District Court’s Post-Trial Ruling in Case Involving GeoMx Digital Spatial Profiler Products
2024-12-23 ET
U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products
2024-12-20 ET
Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility
2024-12-02 ET
Bruker Introduces Dimension Nexus™ Atomic Force Microscope
2024-11-18 ET
Bruker Announces Quarterly Dividend
2024-11-12 ET
Dragonfly Energy and Bruker Partner to Accelerate Battery Technology Development
2024-11-12 ET
Bruker Corporation to Present at Upcoming Investor Conferences
2024-11-08 ET
Bruker Announces EpicIFTM, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform
2024-11-05 12:00 ET
Bruker Reports Third Quarter 2024 Financial Results
2024-10-28 20:05 ET
Bruker Announces Date and Time of Third Quarter 2024 Earnings Release and Webcast
2024-10-21 10:00 ET
Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics
2024-10-17 12:58 ET
European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products
2024-10-11 11:00 ET
Bruker Announces Formation of New Bruker Spatial Biology Division
2024-10-07 11:00 ET
Bruker Introduces Innovative Neuroscience Research Solution with High-Speed OptoVolt Voltage Imaging
2024-10-02 11:00 ET
Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery
2024-08-13 17:35 ET
Bruker Announces Successful Installation of 1.2 GHz Avance® NMR Spectrometer at the Korea Basic Science Institute (KBSI)
2024-08-12 11:00 ET
Bruker Announces Quarterly Dividend
2024-08-07 11:00 ET
Bruker Announces Strategic Minority Investment in NovAliX
2024-08-06 11:00 ET
Bruker Reports Second Quarter 2024 Financial Results
2024-07-31 20:05 ET
Bruker Announces Date and Time of Second Quarter 2024 Earnings Release and Webcast
2024-07-18 11:00 ET
Bruker Announces that Injunction Impacting NanoString’s CosMx Spatial Molecular Imager Products in Germany Has Been Suspended Effective Immediately
2024-07-02 11:00 ET
Bruker Announces Successful Installation of a 1.2 GHz NMR at the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin
2024-06-03 11:00 ET
Bruker Applied Mass Spectrometry Division Showcases High-Performance Solutions for Research and Analysis in Applied Laboratories
2024-06-03 11:00 ET
Bruker Launches Transformative neofleX™ MALDI-TOF System for Spatial Biology Mass Spec Imaging (MSI) Applications
2024-06-03 11:00 ET
Bruker Launches Ultimate Sensitivity timsTOF Ultra 2 to Enable New Research Paradigms in Single-Cell and Subcellular Proteomics
2024-05-31 20:05 ET
Bruker Corporation to Present at Upcoming Investor Conferences
2024-05-29 20:14 ET
Bruker Announces Public Offering of Common Stock
2024-05-16 14:34 ET
Access Reminder for Bruker Investor Webinar on May 17, 2024
2024-05-15 20:05 ET
Bruker Announces Quarterly Dividend
2024-05-09 11:00 ET
Bruker Corporation to Host Investor Webinar on May 17, 2024
2024-05-07 18:04 ET
German Federal Patent Court Invalidates Patent Asserted By 10x Genomics, Delivering Legal Win to NanoString and Bruker
2024-05-06 20:05 ET
Bruker Completes Asset Acquisition of NanoString Business
2024-05-02 11:00 ET
Bruker Reports First Quarter 2024 Financial Results
2024-05-02 11:00 ET
Bruker Completes Acquisition of Molecular Diagnostics Innovator ELITech
2024-04-26 11:00 ET
Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference
2024-04-25 20:01 ET
Bruker Announces Date and Time of First Quarter 2024 Earnings Release and Webcast
2024-04-22 11:00 ET
Bruker to Acquire the NanoString Business in an Asset Deal
2024-04-08 11:00 ET
Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates
2024-04-08 11:00 ET
Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies
2024-04-04 12:11 ET
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
2024-04-01 11:00 ET
Bruker Selected as ‘Company of the Year’ by Instrument Business Outlook
2024-03-11 11:00 ET
Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
2024-03-07 12:00 ET
Bruker Announces Closing of Chemspeed Technologies AG Acquisition
2024-02-28 12:00 ET
Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup
2024-02-26 15:42 ET
Bruker Corporation to Present at Upcoming Investor Conferences
2024-02-16 21:05 ET
Bruker Announces Quarterly Dividend
2024-02-13 12:00 ET
Bruker Reports Fourth Quarter and Full Year 2023 Financial Results
2024-02-07 12:00 ET
Bruker Acquires Nanophoton Corporation, a Japanese Technology Leader in Research Raman Microscopy with 20 Years of Experience
2024-02-06 21:05 ET
Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems
2024-02-06 12:00 ET
Bruker Announces Date and Time of Fourth Quarter 2023 Earnings Release and Webcast
2024-02-05 12:00 ET
Bruker Introduces the Ingenious Novel ‘Triceratops’ SPR #64 Surface Plasmon Resonance System for Drug Discovery at SLAS2024
2024-01-25 12:00 ET
Bruker Announces Agreement to Acquire Chemspeed
2024-01-23 13:30 ET
Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts
2024-01-23 13:00 ET
Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts
2024-01-04 13:00 ET
Bruker Announces Acquisition of Tornado Spectral Systems to Expand Its Biopharma Process Analytical Technology (PAT) Product Portfolio
2024-01-03 21:35 ET
Bruker Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2024-01-03 12:00 ET
Bruker Acquires Electron Microscopy Company Nion
2023-12-19 14:41 ET
Bruker Announces First 1.2 GHz NMR Installation in the United States at The Ohio State University - Funded by the U.S. National Science Foundation
2023-11-20 21:15 ET
Bruker Announces Quarterly Dividend
2023-11-07 14:00 ET
Bruker Corporation to Participate in the 2023 Jefferies London Healthcare Conference
2023-11-02 11:00 ET
Bruker Reports Third Quarter 2023 Financial Results
2023-10-27 15:07 ET
Bruker Announces Date and Time of Third Quarter 2023 Earnings Release and Webcast
2023-10-04 11:00 ET
Bruker Announces Majority Investment in MIRO Analytical AG, an Innovator in Compact, Highest-Precision QCL-Based Multi-Gas Analyzers (MGA)
2023-10-03 11:00 ET
Bruker Completes Acquisition of PhenomeX
2023-10-02 20:05 ET
Bruker Introduces Next-Generation Nanomechanical Test System
2023-09-18 11:00 ET
Bruker Introduces Novel 4D-Proteomics™ timsTOF® Capabilities
2023-09-15 08:06 ET
Biognosys Presents Technological Innovations and Scientific Progress to Make the Proteome Actionable for Life Science Research at the HUPO 2023 World Congress
2023-09-07 11:00 ET
Bruker Announces New Fraport AG Framework Contract for ETD Systems
2023-09-06 11:43 ET
Dragonfly Energy Leverages Cutting-Edge Lithium Battery Research Instrumentation from Bruker
2023-09-05 20:02 ET
PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker
2023-08-24 20:05 ET
Bruker Corporation to Present at the 21st Annual Morgan Stanley Global Healthcare Conference
2023-08-17 13:00 ET
Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction
2023-08-16 20:05 ET
Bruker to Provide 60 Explosives Trace Detectors for Zuerich Airport
2023-08-14 11:00 ET
Bruker Announces Quarterly Dividend
2023-08-03 11:00 ET
Bruker Reports Second Quarter 2023 Financial Results
2023-07-25 20:44 ET
Bruker Announces Date and Time of Second Quarter 2023 Earnings Release and Webcast
2023-07-10 11:00 ET
Bruker Enables Advanced Life-Science and Green-Tech Research in the UK
2023-06-30 11:00 ET
Bruker Announces SciY™ Platform of Advanced Scientific and Automation Software Solutions for the Digital Transformation of the Life Science and Biopharma Industries
2023-06-27 14:00 ET
Bruker Announces New D6 PHASERTM Benchtop X-Ray Diffraction (XRD) Platform for Materials Analysis and Advanced Research
2023-06-14 14:39 ET
Bruker Releases 2023 Sustainability Report
2023-06-05 11:00 ET
PreOmics Introduces New ENRICH-iST Kits and Novel Workflow for Unbiased, Affordable Plasma and Serum Proteomics by LC-MS
2023-06-05 11:00 ET
Bruker Introduces Novel EVOQ™ DART-TQ+ for Chromatography-Free Mass Spectrometry Aimed at the Applied Market Segments
2023-06-05 11:00 ET
Bruker Launches timsTOF Ultra Mass Spectrometer with Transformative Sensitivity, 300 Hz PASEF MS/MS, and VistaScan™ for Enhanced dia-PASEF® 4D-Proteomics™
2023-06-02 11:00 ET
Bruker Corporation to Present at Jefferies 2023 Healthcare Conference
2023-05-31 20:33 ET
Bruker to Host Investor Day on June 15th, 2023
2023-05-15 20:05 ET
Bruker Announces New Two-Year Share Repurchase Authorization of up to $500 Million; Board Declares Quarterly Dividend
2023-05-08 11:00 ET
Bruker Announces Acquisition of ZONTAL to Advance the Digital Laboratory Transformation and Integrated Biopharma Data Solutions
2023-05-04 11:00 ET
Bruker Reports First Quarter 2023 Financial Results
2023-04-26 20:05 ET
Bruker Announces Date and Time of First Quarter 2023 Earnings Release and Webcast
2023-04-17 11:00 ET
Bruker Advances NMR Magnet Portfolio, Innovates in Industrial Solutions
2023-04-14 11:00 ET
Bruker Introduces New Mycobacteria and Fungi IVD Solutions for MALDI Biotyper®, and a Novel LiquidArray® Gastrointestinal Syndromic Panel
2023-04-14 11:00 ET
PreOmics Introduces a Novel BeatBox™ FFPE Workflow for Accelerated, In-depth Tissue Proteomics
2023-04-12 11:00 ET
Canopy Biosciences and Enable Medicine Announce Partnership to Bring Advanced Spatial Analysis Pipelines to the ChipCytometry Platform
2023-03-17 11:00 ET
Bruker Announces Two 1.2 GHz NMR Systems Orders from the UK
2023-03-06 15:30 ET
Bruker Launches de novo Sequencing for Immunopeptidomics, Library-Free dia-PASEF, Mass Dynamics Knowledge Visualization
2023-02-28 07:00 ET
CORRECTING and REPLACING The European Gauss Fusion Initiative Seeks to Use Magnetic Fusion to Ensure a Clean and Safe Energy Supply
2023-02-22 21:15 ET
Bruker Corporation to Present at Investor Conferences
2023-02-17 12:00 ET
Bruker Announces Quarterly Dividend
2023-02-09 12:00 ET
Bruker Reports Fourth Quarter and Fiscal Year 2022 Financial Results
2023-02-03 12:00 ET
Bruker Announces Successful Customer Installations of First Two Compact 1.0 GHz NMR Systems to Advance Structural Biology
2023-01-31 21:05 ET
Bruker Announces Date and Time of Fourth Quarter 2022 Earnings Release and Webcast
2023-01-05 21:34 ET
Bruker Announces Acquisition of ACQUIFER Imaging GmbH
2023-01-04 12:00 ET
Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers
2023-01-04 12:00 ET
Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers
2022-12-21 21:05 ET
Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference
2022-12-16 14:47 ET
Bruker Energy & Supercon Technologies (BEST) Announces Multi-Year Orders for Key Magnetic Confinement Fusion Technologies
2022-11-14 12:00 ET
Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio
2022-11-11 12:00 ET
Bruker Announces Quarterly Dividend
2022-11-08 12:00 ET
Bruker Announces Acquisition of Inscopix for Neuroscience Research
2022-11-07 21:01 ET
Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference
2022-11-03 11:00 ET
Bruker Reports Third Quarter 2022 Financial Results
2022-10-21 20:01 ET
Bruker Announces Date and Time of Third Quarter 2022 Earnings Release and Webcast
2022-08-29 10:00 ET
Bruker Launches New nanoElute® 2 nano-LC For 4D-Proteomics, Advances Fluxomics Applications with MetaboScape® 2023 Software
2022-08-22 11:00 ET
Bruker Introduces Enabling New Scientific Capabilities for Cell Biology and Pathobiology Research with High-Field NMR Innovations
2022-08-12 11:00 ET
Bruker Announces Quarterly Dividend
2022-08-03 20:01 ET
Bruker Reports Second Quarter 2022 Financial Results
2022-07-25 20:01 ET
Bruker Announces Date and Time of Second Quarter 2022 Earnings Release and Webcast
2022-07-20 13:00 ET
Acuamark Diagnostics Secures $11.3 Million Series A Funding to Advance Innovative Assays for Improved, Cost-Effective Early-Cancer Detection
2022-07-11 10:00 ET
Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research
2022-07-06 11:00 ET
Bruker Launches NMR-based Molecular Phenomics Clinical Research Tool for ‘Long COVID’ Multi-Organ Risk Assessment
2022-06-21 11:00 ET
Bruker is Ushering in the Age of Spatial Single-Cell Metabolomics
2022-06-21 10:00 ET
Bruker Presents High-Value Life Science, Materials Research and Applied Market Solutions at Analytica 2022
2022-06-14 11:00 ET
Bruker Introduces Enhanced 3D Holographic Stimulation for Optogenetics on its Ultima 2Pplus Multiphoton Microscope
2022-06-06 11:00 ET
Bruker Launches timsTOF HT with Greater Dynamic Range for Further Enhancing Unbiased, High-Confidence 4D Proteomics™
2022-06-06 11:00 ET
Bruker Introduces Novel Point-of-Need Applied Mass Spectrometry Tools for Accelerated Measurements without Chromatography
2022-06-06 11:00 ET
Bruker Announces Key Innovations for Highly Multiplexed Spatial Proteomics and Multiomic Tissue Imaging at Large Field-of-View
2022-05-25 20:01 ET
Bruker Corporation to Present at Jefferies 2022 Global Healthcare Conference
2022-05-16 11:00 ET
Bruker Announces Quarterly Dividend
2022-05-10 11:00 ET
Bruker and TOFWERK Form Strategic Partnership in High-Speed, Ultra-Sensitive Solutions for Applied and Industrial Markets
2022-05-09 16:52 ET
Bruker Launches Novel 7 Tesla and 9.4 Tesla Preclinical MRI Magnets
2022-05-04 11:00 ET
Bruker Reports First Quarter Financial Results
2022-04-25 11:00 ET
Bruker Demonstrates Novel and Unique Compact 1.0 GHz NMR Magnet
2022-04-22 11:00 ET
Bruker Launches Unique LiquidArray® Multiplex PCR Assays
2022-04-18 20:05 ET
Bruker Announces Date and Time of First Quarter 2022 Earnings Release and Webcast
2022-04-11 14:24 ET
Bruker Announces Key Innovations for Multiplexed Spatial Proteomics and Unbiased Multiomic Imaging for Cancer Research
2022-04-06 15:00 ET
IonSense, a Leader In DART™ Mass Spectroscopy, Announces Acquisition by Bruker to Accelerate DART-MS Methods and Applications Development
2022-04-05 11:00 ET
Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies
2022-04-04 11:10 ET
Bruker Expands dia-PASEF® on the timsTOF 4D Proteomics and Epiproteomics Platform to Identify up to 13,000 Protein Groups with 1% FDR
2022-03-16 13:46 ET
Bruker Appoints Philip Ma to its Board of Directors
2022-03-10 14:40 ET
Announcing New Fourier 80 Benchtop FT-NMR Capabilities for Pharmaceutical and Food Analysis Markets
2022-03-03 19:00 ET
Canopy Biosciences Launches Next-Generation ChipCytometry™ Instrument for Spatial Biology with Sub-Cellular Resolution
2022-03-02 16:15 ET
Newomics and Bruker Announce Collaborations on High-throughput Bioanalysis
2022-02-28 16:05 ET
Bruker Releases CCS-Enabled TIMScore™ and TIMS DIA-NN 4D Proteomics Software
2022-02-28 12:00 ET
Bruker Corporation to Present at Cowen’s 42nd Annual Health Care Conference
2022-02-18 12:00 ET
Bruker Announces Quarterly Dividend
2022-02-11 12:00 ET
Bruker Reports Fourth Quarter and Fiscal Year 2021 Financial Results
2022-02-10 12:00 ET
Bruker Corporation to Present at the 11th Annual SVB Leerink Global Healthcare Conference
2022-02-07 16:01 ET
IonOpticks enters OEM partnership with Bruker that sets a new standard for mass spectrometry-based research
2022-02-07 12:01 ET
Bruker Enables High-Throughput Multiplex HTS on Sierra SPR Platform
2022-02-07 12:00 ET
Bruker Launches New timsTOF-based MALDI PharmaPulse® Solution for Label-free HTS in Drug Discovery
2022-02-04 12:00 ET
Bruker Expands Nanoflow Consumables Portfolio for 4D-Proteomics™
2022-02-02 12:00 ET
Bruker Announces Date and Time of Fourth Quarter 2021 Earnings Release and Webcast
2022-01-19 12:00 ET
Bruker Acquires Prolab Instruments to Augment Multiomics Solutions
2022-01-04 12:00 ET
Bruker Corporation to Present at the 40th Annual J.P. Morgan Healthcare Conference
2021-12-20 12:00 ET
Bruker Introduces Fast BioAFM for Automated Mechanobiology
2021-12-08 12:00 ET
Bruker Announces $500 Million Private Placement of Senior Notes to Support Strategic Growth Objectives
2021-12-02 16:43 ET
Bruker Expects its FluoroType® SARS-CoV-2 varID Q PCR Assay to Reliably Detect and Tentatively Differentiate Omicron (B.1.1.529) Variant
2021-11-19 12:00 ET
Bruker Announces Acquisition of MOLECUBES NV
2021-11-16 12:00 ET
Bruker Announces Collaborative Advances in CCS-Enabled 4D Proteomics Workflows at HUPO
2021-11-15 12:00 ET
Bruker Announces Fourth Quarter 2021 Dividend
2021-11-09 12:00 ET
Bruker Corporation to Participate in the 2021 Jefferies London Healthcare Conference
2021-11-02 11:00 ET
Bruker Announces Major Advances in CCS-Enabled 4D Proteomics at ASMS
2021-11-01 20:05 ET
Bruker Reports Third Quarter 2021 Financial Results
2021-10-18 20:10 ET
Bruker Announces Date and Time of Third Quarter 2021 Earnings Release and Webcast
2021-10-01 11:00 ET
NSF-Funded Network for Advanced NMR Orders Two 1.1 GHz NMR Systems to Advance Protein Structure and Dynamics Research
2021-08-30 20:10 ET
Bruker Corporation to Participate in the 2021 Wells Fargo Virtual Healthcare Conference
2021-08-06 11:00 ET
Bruker Announces Quarterly Dividend
2021-08-02 20:05 ET
Bruker Reports Second Quarter 2021 Financial Results
2021-07-21 11:00 ET
Bruker Announces Date and Time of Second Quarter 2021 Earnings Release and Webcast
2021-06-21 12:00 ET
Novel 4D-Metabolomics and 4D-Lipidomics Workflows, Libraries and ML-based CCS Prediction Tools to Transform Metabolomics and Lipidomics
2021-06-17 12:00 ET
Bruker Updates FY 2021 Guidance and Provides Medium Term Outlook at Virtual Investor Day
2021-06-07 12:00 ET
Bruker to Host Virtual Investor Day on June 17th, 2021
2021-06-07 11:00 ET
Bruker Launches CE-IVD Quantitative Coronavirus Mid-Plex PCR Assay with Mutation Detection for Routine Variant Differentiation
2021-06-01 11:00 ET
Bruker Launches timsTOF trueSCP for Unbiased Single Cell 4D-Proteomics and Next-gen timsTOF Pro 2 with Unprecedented Proteomic Depth
2021-05-20 14:12 ET
Bruker’s Molecular Phenomics Research Tools Enable New Insights into ‘Long COVID’ and Post-Acute Metabolic Abnormalities
2021-05-13 12:00 ET
Bruker Announces New Two-Year Share Repurchase Authorization of up to $500 Million; Board also Declares Quarterly Dividend
2021-05-10 11:14 ET
International Organization of Vine and Wine (OIV) Officially Incorporates NMR Method in Compendium of International Methods of Analysis of Wines and Musts
2021-05-07 11:00 ET
Bruker Corporation to Present at Investor Conferences
2021-05-05 11:00 ET
Bruker Reports First Quarter 2021 Financial Results
2021-04-13 20:10 ET
Bruker Announces First Quarter 2021 Preliminary Revenue
2021-03-29 13:00 ET
Cambridge Isotope Laboratories, Inc and Bruker Biospin Announce Strategic Partnership for the Global Distribution of CIL's NMR Solvents
2021-03-29 11:00 ET
Gigahertz-class NMR Opens New Scientific Windows on Functional Structural Biology in Neurodegenerative Disease and Aging Research
2021-03-26 11:00 ET
Bruker Makes Routine Magnetic Resonance Spectroscopy More Broadly Accessible for Chemical Analysis Outside Central Labs
2021-03-24 11:00 ET
Bruker Light-Sheet Microscopes at Major Comprehensive Cancer Center
2021-03-18 11:00 ET
Acuity Spatial Genomics Announces Formation to Open up New Frontiers for in situ, Spatial 3D Genomics
2021-03-10 21:59 ET
GlycoPath Inc. Secures Seed Investment to Further Develop, Validate and Commercialize GlycoTyper™ Mass Spectrometry-Based Assays for Liver Fibrosis, Cirrhosis and Liver Cancer (HCC)
2021-03-08 14:22 ET
Bruker Announces New Results in Deep, Unbiased Plasma Proteomics, PaSER 1.1 Software and New Cross-linking Consumables at US HUPO 2021
2021-02-25 13:41 ET
New Nature Communications Publication by Mann & Theis Groups Harnesses the Benefits of Large-scale Peptide Collisional Cross Section (CCS) Measurements and Deep Learning for 4D Proteomics
2021-02-22 12:00 ET
Bruker Corporation to Present at Investor Conferences
2021-02-18 12:00 ET
Bruker Announces Quarterly Dividend
2021-02-16 12:00 ET
Bruker Reports Fourth Quarter and Fiscal Year 2020 Financial Results
2021-02-02 21:05 ET
Bruker Announces Date and Time of Fourth Quarter 2020 Earnings Release and Webcast
2021-01-28 09:19 ET
Avacta Announces Collaboration Agreement With Bruker
2021-01-07 12:00 ET
GHz-Class NMR Opens New Scientific Research Window for Discoveries and Novel Insights in Functional Structural Biology and Disease Biology
2021-01-06 12:00 ET
Bruker Corporation to Present at the 39th Annual J.P. Morgan Healthcare Conference
2021-01-05 12:00 ET
Bruker and Evosep Announce Major Progress in Unbiased, Quantitative True Single-cell Proteomics
2021-01-04 12:00 ET
Bruker Introduces MBT Sepsityper® Kit US IVD for Rapid and Affordable Identification of over 400 Microorganisms from Positive Blood Cultures
2020-12-18 12:00 ET
Bruker Launches FluoroType® SARS-CoV-2/Flu/RSV PCR Panel in Europe with CE-IVD Mark
2020-11-16 12:30 ET
Bruker Corporation to Participate in the Jefferies Virtual London Healthcare Conference
2020-11-13 12:00 ET
Bruker Announces Quarterly Dividend
2020-11-02 21:05 ET
Bruker Reports Third Quarter 2020 Financial Results
2020-10-21 11:00 ET
Bruker Introduces Vutara™ VXL Best-in-Class Super-Resolution Microscope and Spatial Biology Analysis Capabilities
2020-10-20 11:00 ET
Bruker Announces Date and Time of Third Quarter 2020 Earnings Release and Webcast
2020-10-19 11:00 ET
Bruker Introduces Routine Gradient Spectroscopy and Robust, Industry-Standard PAL® Automation on High-Performance Fourier™ 80 Benchtop FT-NMR System
2020-10-19 10:00 ET
Bruker Introduces PaSER™ Software for ‘Run and Done’ 4D- ProteomicsTM and TIMS/PASEF Method Wins HUPO 2020 Award
2020-09-30 11:00 ET
Bruker Announces Acquisition of Integrated Proteomics Pipeline (IP2) Software Platform for Large Cohort Translational Studies
2020-09-11 11:00 ET
Bruker Announces Acquisition of Canopy Biosciences, LLC
2020-09-08 11:00 ET
Bruker Appoints Bonnie H. Anderson to its Board of Directors
2020-09-04 11:00 ET
Bruker Corporation to Participate in the 2020 Wells Fargo Virtual Healthcare Conference
2020-08-10 11:00 ET
Bruker Supports International Covid19-NMR Consortium for Structure-Function and Inhibitor Binding Investigations of SARS-CoV-2 RNA and Proteins
2020-08-07 12:00 ET
Bruker Announces Quarterly Dividend
2020-08-07 11:00 ET
Utrecht University and Bruker Announce Collaboration to Develop Methods for Studying Protein Structures and Interactions by Mass Spectrometry
2020-08-03 20:05 ET
Bruker Reports Second Quarter 2020 Financial Results
2020-07-30 11:00 ET
Bruker Launches Revolutionary High-Speed AFM System for Single-Molecule Applications
2020-07-27 11:00 ET
Bruker Launches Second-Generation FluoroType® SARS-CoV-2 plus PCR Test for Detection of SARS-CoV-2 Viral Infections in Europe
2020-07-22 12:30 ET
Successful Installation of ETH 1.2 GHz NMR System Enables Novel Research Capabilities in Solid-State NMR
2020-07-20 20:10 ET
Bruker Announces Date and Time of Second Quarter 2020 Earnings Release and Webcast
2020-07-10 09:00 ET
Inscopix Announces Collaboration With Bruker for Advanced Analysis of Brain Circuits by Combining Miniature Microscopes With Multiphoton Microscopy
2020-05-29 11:00 ET
Bruker Introduces Breakthrough MALDI-2 Source on timsTOF fleX, and Further Innovations in CCS-Enabled 4D Proteomics on timsTOF
2020-05-13 11:00 ET
Bruker Announces Quarterly Dividend
2020-05-12 20:10 ET
Bruker Corporation to Present at Virtual Investor Conferences
2020-05-11 12:00 ET
Bruker Announces Virtual Meeting Option for the Company’s 2020 Annual Stockholders Meeting
2020-05-06 20:05 ET
Bruker Reports First Quarter 2020 Financial Results
2020-05-04 11:00 ET
Successful Installation of World’s First 1.2 GHz NMR System Enables Novel Functional Structural Biology Research
2020-04-22 11:00 ET
Bruker Announces Date and Time of First Quarter 2020 Earnings Release and Webcast
2020-04-01 11:00 ET
Bruker Highlights New Analytical Systems and Applied Market Solutions
2020-03-27 21:05 ET
Bruker Announces Final Fourth Quarter and Fiscal Year 2019 Financial Results
2020-03-24 20:05 ET
Bruker Announces Launch of CE-IVD Marked genesig® Assay Kit for the Detection of the SARS-CoV-2 Virus
2020-03-09 11:00 ET
New Functional Structural Biology Capabilities Enabled by Bruker GHz-Class NMR Technology
2020-01-28 12:00 ET
Bruker Announces Date and Time of Fourth Quarter 2019 Earnings Release and Webcast
2019-12-12 13:33 ET
Bruker Completes Debt Financing to Support Corporate Strategic Objectives
2019-11-15 12:00 ET
Bruker Corporation to Present at Investor Conferences
2019-11-14 12:00 ET
Bruker Announces Quarterly Dividend
2019-10-31 20:05 ET
Bruker Reports Third Quarter 2019 Financial Results
2019-10-21 11:00 ET
Bruker Announces Date and Time of Third Quarter 2019 Earnings Release and Webcast
2019-10-02 11:00 ET
Bruker Announces Acquisition of Magnettech's EPR Business
2019-09-20 11:00 ET
Strategic Alliance between Murdoch University and Bruker Supports International Centre of Excellence in Metabolic Phenotyping
2019-09-16 08:00 ET
Bruker Announces Release of Breakthrough diaPASEF Workflow for CCS-aware 4D Proteomics on timsTOF(TM) Pro Platform at HUPO 2019
2019-09-11 11:00 ET
Bruker Launches Nanoscale Infrared Spectroscopy and Chemical Imaging SNOM/AFM Microscopy System with Broadband Femtosecond IR Laser
2019-09-02 11:00 ET
Bruker Launches Highest Resolution Large-Format Bio-AFM System
2019-08-26 11:00 ET
Bruker Announces World's First 1.2 GHz High-Resolution Protein NMR Data
2019-08-12 11:00 ET
Bruker Announces Quarterly Dividend
2019-08-01 20:05 ET
Bruker Reports Second Quarter 2019 Financial Results
2019-07-23 20:05 ET
Bruker Announces Date and Time of Second Quarter 2019 Earnings Release and Webcast
2019-07-17 11:00 ET
Bruker Comments on Block Trade Transaction
2019-07-08 11:00 ET
Bruker Announces Acquisition of Preclinical and Molecular Imaging Research Software Provider PMOD Technologies LLC
2019-06-20 11:00 ET
Bruker Launches MALDI Biotyper Sirius at ASM Microbe Conference
2019-06-14 11:00 ET
Bruker to Host Investor Day on June 20th, 2019
2019-05-31 16:54 ET
Bruker Launches timsTOF fleX(TM)  with ESI and MALDI for SpatialOMx(TM)
2019-05-28 19:00 ET
Bruker Corporation to Present at Jefferies 2019 Global Healthcare Conference
2019-05-13 11:00 ET
Bruker and Champalimaud Foundation Announce Collaboration to Develop Novel Ultra-High Field 18 Tesla Preclinical MRI System and Applications
2019-05-10 11:00 ET
Bruker Announces New $300 Million Share Repurchase Authorization and Quarterly Dividend
2019-05-02 20:06 ET
Bruker Reports First Quarter 2019 Financial Results
2019-04-23 11:00 ET
Bruker Announces Date and Time of First Quarter 2019 Earnings Release and Webcast
2019-04-15 11:00 ET
Bruker Announces Further Portfolio Expansion for Microbial Identification, Infection Control and Molecular Diagnostics of Infectious Diseases
2019-04-08 11:00 ET
Bruker Announces World's First Superconducting 1.1 Gigahertz Magnet for High-Resolution NMR in Structural Biology
2019-04-03 11:00 ET
Bruker Announces Acquisition of RAVE LLC

SEC forms

Show financial reports only

SEC form 10
2026-08-05 20:24 ET
Bruker published news for 2026 q2
SEC form 8
2026-08-04 11:00 ET
Bruker published news for 2026 q2
SEC form 8
2026-08-04 11:00 ET
Bruker published news for 2026 q2
SEC form 10
2026-05-07 20:09 ET
Bruker published news for 2026 q1
SEC form 8
2026-05-06 10:30 ET
Bruker published news for 2026 q1
SEC form 8
2026-05-06 10:30 ET
Bruker published news for 2026 q1
SEC form 10
2026-02-27 21:04 ET
Bruker published news for 2025 q4
SEC form 8
2026-02-12 12:00 ET
Bruker reported for 2025 q4
SEC form 8
2026-02-12 12:00 ET
Bruker published news for 2025 q4
SEC form 8
2026-01-12 17:00 ET
Bruker published news for 2025 q4
SEC form 8
2025-11-03 07:00 ET
Bruker published news for 2025 q3
SEC form 8
2025-11-03 07:00 ET
Bruker reported for 2025 q3
SEC form 8
2025-08-04 11:00 ET
Bruker published news for 2025 q2
SEC form 8
2025-08-04 11:00 ET
Bruker reported for 2025 q2
SEC form 8
2025-07-21 00:00 ET
Bruker published news for 2025 q2
SEC form 8
2025-07-21 00:00 ET
Bruker published news for 2025 q2
SEC form 10
2025-05-07 20:04 ET
Bruker reported for 2025 q1
SEC form 8
2025-05-07 11:00 ET
Bruker published news for 2025 q1
SEC form 8
2025-05-07 11:00 ET
Bruker published news for 2025 q1
SEC form 10
2025-05-07 00:00 ET
Bruker published news for 2025 q1
SEC form 8
2025-04-11 00:00 ET
Bruker published news for 2025 q1
SEC form 8
2025-04-11 00:00 ET
Bruker published news for 2025 q1
SEC form 10
2025-03-03 00:00 ET
Bruker published news for 2024 q4
SEC form 8
2025-02-13 00:00 ET
Bruker reported for 2024 q4
SEC form 8
2025-02-13 00:00 ET
Bruker published news for 2024 q4
SEC form 8
2025-01-13 00:00 ET
Bruker published news for 2024 q4
SEC form 10
2024-11-07 16:06 ET
Bruker published news for 2024 q3
SEC form 8
2024-11-05 07:00 ET
Bruker published news for 2024 q3
SEC form 8
2024-11-05 07:00 ET
Bruker published news for 2024 q3
SEC form 10
2024-08-09 00:00 ET
Bruker published news for 2024 q2
SEC form 8
2024-08-06 07:00 ET
Bruker published news for 2024 q2
SEC form 8
2024-08-06 07:00 ET
Bruker reported for 2024 q2
SEC form 10
2024-05-10 00:00 ET
Bruker published news for 2024 q1
SEC form 8
2024-05-02 07:00 ET
Bruker published news for 2024 q1
SEC form 8
2024-05-02 07:00 ET
Bruker reported for 2024 q1
SEC form 10
2024-02-29 00:00 ET
Bruker published news for 2023 q4
SEC form 8
2024-02-13 00:00 ET
Bruker published news for 2023 q4
SEC form 8
2024-02-13 00:00 ET
Bruker reported for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Bruker published news for 2023 q4
SEC form 10
2023-11-09 00:00 ET
Bruker published news for 2023 q3
SEC form 8
2023-11-02 07:00 ET
Bruker reported for 2023 q3
SEC form 10
2023-08-09 00:00 ET
Bruker published news for 2023 q2
SEC form 6
2023-08-03 07:01 ET
Bruker reported for 2023 q2
SEC form 8
2023-08-03 00:00 ET
Bruker published news for 2023 q2
SEC form 6
2023-06-07 17:16 ET
Bruker published news for 2023 q1
SEC form 10
2023-05-10 00:00 ET
Bruker published news for 2023 q1
SEC form 8
2023-05-04 00:00 ET
Bruker published news for 2023 q1
SEC form 10
2023-03-01 00:00 ET
Bruker reported for 2022 q4
SEC form 8
2023-02-09 00:00 ET
Bruker reported for 2022 q4
SEC form 8
2023-01-09 00:00 ET
Bruker published news for 2022 q4
SEC form 10
2022-11-04 00:00 ET
Bruker reported for 2022 q3
SEC form 8
2022-11-03 00:00 ET
Bruker reported for 2022 q3
SEC form 10
2022-08-05 00:00 ET
Bruker reported for 2022 q2
SEC form 8
2022-08-03 00:00 ET
Bruker reported for 2022 q2
SEC form 10
2022-05-06 00:00 ET
Bruker reported for 2022 q1
SEC form 8
2022-05-04 00:00 ET
Bruker reported for 2022 q1
SEC form 10
2022-02-28 00:00 ET
Bruker published news for 2021 q4
SEC form 8
2022-02-11 00:00 ET
Bruker published news for 2021 q4
SEC form 8
2022-01-10 00:00 ET
Bruker published news for 2021 q4
SEC form 10
2021-11-05 00:00 ET
Bruker published news for 2021 q3
SEC form 8
2021-11-01 00:00 ET
Bruker published news for 2021 q3
SEC form 10
2021-08-05 00:00 ET
Bruker published news for 2021 q2
SEC form 8
2021-08-02 00:00 ET
Bruker published news for 2021 q2
SEC form 10
2021-05-10 00:00 ET
Bruker published news for 2021 q1
SEC form 8
2021-05-05 00:00 ET
Bruker published news for 2021 q1
SEC form 8
2021-04-13 00:00 ET
Bruker published news for 2021 q1